EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations

Frode Selheim, Elise Aasebø iD, Håkon Reikvam iD, Øystein Bruserud, Maria Hernandez-Valladares iD

International Journal of Molecular Sciences · 07.05.2024 · 25 (10) · 5080

DOI: 10.3390/ijms25105080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2024. Verfasst von Frode Selheim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Unit of University of Bergen (PROBE), University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway. Hauptthemen laut MEDLINE: Cell Differentiation, Leukemia, Myeloid, Acute, Mutation, Nucleophosmin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Norwegian Cancer Society, Research Council of Norway INFRASTRUKTUR-program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Even though morphological signs of differentiation have a minimal impact on survival after intensive cytotoxic therapy for acute myeloid leukemia (AML), monocytic AML cell differentiation (i.e., classified as French/American/British (FAB) subtypes M4/M5) is associated with a different responsiveness both to Bcl-2 inhibition (decreased responsiveness) and possibly also bromodomain inhibition (increased responsiveness). FAB-M4/M5 patients are heterogeneous with regard to genetic abnormalities, even though monocytic differentiation is common for patients with Nucleophosmin 1 (NPM1) insertions/mutations; to further study the heterogeneity of FAB-M4/M5 patients we did a proteomic and phosphoproteomic comparison of FAB-M4/M5 patients with (n = 13) and without (n = 12) NPM1 mutations. The proteomic profile of NPM1-mutated FAB-M4/M5 patients was characterized by increased levels of proteins involved in the regulation of endocytosis/vesicle trafficking/organellar communication. In contrast, AML cells without NPM1 mutations were characterized by increased levels of several proteins involved in the regulation of cytoplasmic translation, including a large number of ribosomal proteins. The phosphoproteomic differences between the two groups were less extensive but reflected similar differences. To conclude, even though FAB classification/monocytic differentiation are associated with differences in responsiveness to new targeted therapies (e.g., Bcl-2 inhibition), our results shows that FAB-M4/M5 patients are heterogeneous with regard to important biological characteristics of the leukemic cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationLeukemia, Myeloid, AcuteMutationNucleophosminProteomicsAdultAgedFemaleHumansMaleMiddle AgedMonocytesNuclear ProteinsPhosphoproteins

Stichwörter der Autor:innen

FAB classificationNucleophosmin 1 mutationsacute myeloid leukemiadifferentiationendocytosismonocytictranscription

Substanzen

NPM1 protein, humanNuclear ProteinsNucleophosminPhosphoproteins

Autor:innen und Institutionen

  • Proteomics Unit of University of Bergen (PROBE), University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
  • Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
  • Section for Hematology, Department of Medicine, Haukeland University Hospital, 5009 Bergen, Norway.
  • Department of Physical Chemistry, University of Granada, Avenida de la Fuente Nueva S/N, 18071 Granada, Spain.
  • Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.

ORCID-Profile: Elise Aasebø, Håkon Reikvam, Maria Hernandez-Valladares

Förderung

  • Wellcome Trust
  • Norwegian Cancer Society
  • Research Council of Norway INFRASTRUKTUR-program

Zitieren

APA

Selheim, F., Aasebø, E., Reikvam, H., Bruserud, Ø., & Hernandez-Valladares, M. (2024). Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. International Journal of Molecular Sciences, 25(10), 5080. https://doi.org/10.3390/ijms25105080

Vancouver

Selheim F, Aasebø E, Reikvam H, Bruserud Ø, Hernandez-Valladares M. Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations. International Journal of Molecular Sciences. 2024;25(10):5080. doi:10.3390/ijms25105080

BibTeX
@article{Selheim2024,
  author = {Selheim, Frode and Aasebø, Elise and Reikvam, Håkon and Bruserud, Øystein and Hernandez-Valladares, Maria},
  title = {Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5080},
  doi = {10.3390/ijms25105080}
}
Kostenlos starten →